Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFPChoosing and Responding to Government Bids
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›AJ13--Pharmarcokinetics for Experimental Rheumatoid…

U.S. Department Of Veterans Affairs·Maryland

AJ13--Pharmarcokinetics for Experimental Rheumatoid Arthritis treatment

Closes 7/31/2026$500k – $2MRequest for Proposal
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Department of Veterans Affairs is seeking a contractor to perform preclinical toxicology and pharmacokinetic studies to support the advancement of an experimental joint-targeted liposomal delivery system for Rheumatoid Arthritis therapy. The contractor will be required to perform GLP-compliant toxicity studies and GLP or non-GLP pharmacokinetic studies in adult rats. The studies will include clinical observations, weight/food intake monitoring, blood chemistry assessments, necropsy, and histopathology. The contractor will also be required to provide a comprehensive final written report covering toxicity results, PK data, and analytical findings. The key aspects of this opportunity include: • Preclinical toxicology and pharmacokinetic studies • GLP-compliant toxicity studies and GLP or non-GLP pharmacokinetic studies • Adult rats as the test subjects • Clinical observations, weight/food intake monitoring, blood chemistry assessments, necropsy, and histopathology • Comprehensive final written report

Attached files

Contact

Robert O'Keefe Jr.(Contract Specialist)

[email protected]

Key dates

Opened
7/16/2026
Closes
7/31/2026
Duration
1 years

Last updated

Details

Type
Request for Proposal
Industry
Healthcare and Medical Services
NAICS
112990
Solicitation №
36C24526Q0669

Budget estimate

$500,000 – $2,000,000

The budget for this opportunity is difficult to estimate, as the document does not provide a specific amount. However, based on the scope of the project, which includes preclinical toxicology and pharmacokinetic studies, the budget could be in the range of $500,000 to $2,000,000. This estimate is based on the assumption that the contractor will need to perform a significant amount of research and testing, which can be costly. Additionally, the contractor will need to provide a comprehensive final written report, which may also add to the overall cost.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Food and Drug Administration·United States of America

Top match · 68%

Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional

Rolling / TBD closeOpened 11/21/2023

U.S. Food and Drug Administration·United States of America

67% match

Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)

Rolling / TBD closeOpened 11/24/2023

U.S. Food and Drug Administration·United States of America

65% match

Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Health And Human Services·United States of America

65% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

U.S. Department Of Defense·Pennsylvania

65% match

Atropine Auto-Injector

Closes 11/30/2026Opened 10/29/2026

U.S. Food and Drug Administration·United States of America

65% match

Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

65% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 11/5/2027Opened 11/15/2021

U.S. Food and Drug Administration·United States of America

64% match

Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Veterans Affairs·Missouri

64% match

AJ12--Development/Production - Kidney GEC-Specific AAV Vector

Closes 11/4/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

64% match

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases

Closes 3/3/2027Opened 6/10/2026

U.S. Department Of Health And Human Services·United States of America

63% match

Synthesis and Distribution of Drugs of Abuse and Related Compounds

Closes 11/20/2026Opened 10/29/2026

U.S. National Institutes of Health·United States of America

63% match

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Closes 1/15/2027Opened 9/18/2024

U.S. Department Of Health And Human Services·Maryland

63% match

Reagents and consumables for Roche immunostainers

Closes 11/16/2026Opened 10/30/2026

U.S. Department Of Transportation·United States of America

63% match

Experimental and Mathematical Biomechanics Injury Research IDIQ

Closes 11/30/2026Opened 10/15/2026

U.S. National Institutes of Health·United States of America

63% match

Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)

Closes 11/9/2026Opened 2/12/2026

U.S. National Institutes of Health·United States of America

63% match

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. Food and Drug Administration·United States of America

63% match

Center for Research on Complex Generics (U18) Clinical Trials Optional

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

63% match

Translational Bioinformatics and Experimental Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Closes 5/7/2028Opened 12/30/2024

U.S. Department Of Veterans Affairs·California

63% match

6550--Blood Type IVD Reagents

Closes 11/16/2026Opened 10/30/2026

U.S. Food and Drug Administration·United States of America

62% match

Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed

Rolling / TBD closeOpened 8/14/2024

U.S. Department Of Defense·Maryland

62% match

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Closes 10/18/2028Opened 9/23/2026

U.S. National Institutes of Health·United States of America

62% match

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

Closes 2/17/2028Opened 5/28/2025

U.S. National Institutes of Health·United States of America

62% match

Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional)

Closes 11/10/2026Opened 3/3/2026

U.S. Department Of Defense·Pennsylvania

62% match

Epinephrine Injector

Closes 11/2/2026Opened 4/29/2026

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

62% match

DoW Orthopaedic, Applied Research Award

Closes 11/18/2026Opened 5/21/2026